Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
Fulvestrant
×
Clear all
Filters
3
NCT01602380
2026-02-27
FALCON
AstraZeneca
Phase 3
Completed
462 enrolled
20 charts
NCT02437318
2025-02-13
SOLAR-1
Novartis
Phase 3
Completed
572 enrolled
22 charts
1 FDA
NCT02422615
2023-11-30
MONALEESA-3
Novartis
Phase 3
Completed
726 enrolled
17 charts
1 FDA
NCT00256698
2012-08-01
FACT
AstraZeneca
Phase 3
Completed
514 enrolled
13 charts